Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
121 Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients Department of Clinical Pathology Eman Hosny Mohammed Ibrahim 2021
122 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
123 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Prof. Mostafa El-Sayed Abdalones Mohamed 2021
124 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2021
125 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
126 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Biostatistics and Cancer Epidemiology Basma Rezk Farouk Saleh 2021
127 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Pediatric Oncology Dr. Aminh Naje Abdul Hameed Jad Elarab 2021
128 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study 		Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2021
129 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
 		Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
130 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021